Literature DB >> 10586938

Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.

H Ohguro1, K Ogawa, T Maeda, A Maeda, I Maruyama.   

Abstract

PURPOSE: In a previous study, both recoverin and heat shock cognate protein 70 (hsc 70) were found as autoantigens recognized by sera from four patients with cancer-associated retinopathy (CAR). This observation suggested that autoimmune reactions against recoverin and hsc 70 might be involved together in the pathogenesis of CAR. The purpose of the present study is to investigate the effects of these autoantibodies on retinas in vivo.
METHODS: Functional and morphologic properties of the retinas were evaluated after anti-recoverin and/or anti-hsc 70 antibodies were intravitreously injected into Lewis rats' eyes.
RESULTS: Responses in electroretinogram (ERG) of eyes penetrated with anti-hsc 70 antibody were comparable with the control, but those with anti-recoverin antibody were remarkably reduced during the 3-week period after the injection. Such anti-recoverin antibody-induced reduction was significantly enhanced by copenetration with anti-hsc 70 antibody. Immunofluorescence microscopy demonstrated that after intravitreal injection, anti-recoverin antibody penetrated toward the outer nuclear layer (ONL) and outer segments within 12 to 24 hours, and the presence of the antibody in the retina diminished during the next few days. Histopathology revealed significant thinning of the ONL and inner nuclear layer (INL) in the affected retina in comparison with the control. Throughout the ONL and INL, apoptotic cells were recognized by TdT-dUTP terminal nick-end labeling. The antibody-induced retinal dysfunction was effectively treated by administrations of either corticosteroid or cyclosporin A.
CONCLUSIONS: These observations suggest that anti-recoverin- and anti-hsc 70 antibody-induced retinal dysfunction in Lewis rat is a good model to study the pathophysiology of CAR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586938

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  24 in total

1.  Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.

Authors:  R Peek; B G Dijkstra; B Meek; R W A M Kuijpers
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

2.  Evolution in medical decision making.

Authors:  Matej Sprogar; Mitja Lenic; Silvia Alayon
Journal:  J Med Syst       Date:  2002-10       Impact factor: 4.460

Review 3.  The need for standardization of antiretinal antibody detection and measurement.

Authors:  Farzin Forooghian; Ian M Macdonald; John R Heckenlively; Elise Héon; Lynn K Gordon; John J Hooks; Barbara Detrick; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

4.  Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy.

Authors:  Grazyna Adamus; Landon Karren
Journal:  J Autoimmun       Date:  2009-03-06       Impact factor: 7.094

Review 5.  The enigma of autoimmune retinopathy.

Authors:  Farzin Forooghian; Sijia Cao; Jing Cui; Joanne A Matsubara
Journal:  Int Ophthalmol Clin       Date:  2015

Review 6.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  Optical coherence tomography findings in autoimmune retinopathy.

Authors:  Azin Abazari; Souha S Allam; Grazyna Adamus; Nicola G Ghazi
Journal:  Am J Ophthalmol       Date:  2012-01-14       Impact factor: 5.258

8.  Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

Authors:  Grazyna Adamus
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-09       Impact factor: 4.799

9.  The effect of topical anesthesia on the rat electroretinogram.

Authors:  Shai Sandalon; Ron Ofri
Journal:  Doc Ophthalmol       Date:  2008-07-30       Impact factor: 2.379

10.  Two mouse models for recoverin-associated autoimmune retinopathy.

Authors:  Ying Lu; Shirley He; Lin Jia; Naheed W Khan; John R Heckenlively
Journal:  Mol Vis       Date:  2010-10-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.